Table 2. Summary of HCV-related tests available by type of health facility (2021).
| Teaching | Regional | District | CHAG | Total n/N (%) | |
|---|---|---|---|---|---|
| Diagnostics | |||||
| Anti-HCV (RDT) | 5/5 | 6/6 | 3/3 | 3/3 | 17/17 (100) |
| Anti-HCV (serology) | 4/5 | 3/6 | 0/3 | 0/3 | 7/17 (41.2) |
| HCV cAg | 0/5 | 0/6 | 0/3 | 0/3 | 0/17 (0) |
| HCV RNA* | 2/5 | 0/6 | 0/3 | 0/3 | 2/17 (11.8) |
| HCV Genotyping | 1/5 | 0/6 | 0/3 | 0/3 | 1/17 (5.9) |
| Therapeutics | |||||
| Pan-genotypic therapy** | 0/5 | 0/6 | 0/3 | 0/3 | 0/17(0) |
HCV = Hepatitis C virus, RDT = Rapid Diagnostic Test, cAg = Core antigen, RNA = Ribonucleic acid.
*One site performed test on-site, and the other outsourced to a private laboratory.
**Medication was not available in the hospital pharmacy but was available on request from private pharmacies.